Related Experiment Videos
To CHOP or not to CHOP ... is that the question?
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Curability Potential of Low-Grade Follicular Lymphoma.
Clinical lymphoma, myeloma & leukemia·2025
Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2009
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2007
High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication.
Annals of oncology : official journal of the European Society for Medical Oncology·2006
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Eight-year outcomes of testosterone suppression plus enzalutamide or a non-steroidal anti-androgen for metastatic, hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma: 5-year follow-up results from CheckMate 648.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
SKYSCRAPER-03: A Phase III Study of Tiragolumab Plus Atezolizumab Versus Durvalumab in Locally Advanced, Unresectable, Stage III NSCLC After Platinum-Based Concurrent Chemoradiation.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
A multimodal deep learning model for preoperative prediction of post-operative complications in gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Should there be informed decision-making for prostate cancer screening? An analysis of preference sensitivity.
Journal of medical screening·2026
Where is the Squad? Robust ideal point estimation in the presence of protest votes.
Journal of applied statistics·2026
Underestimating Honesty in Distributive Negotiations: Misjudging Counterparts' Motivations.
Personality & social psychology bulletin·2026
Why do we seek information about the future? On the origins of subjective value without instrumental value.
bioRxiv : the preprint server for biology·2026
Advance directives in psychiatry to foster self-determination: a proposal for the Italian scenario.
Medicine, health care, and philosophy·2026